All Stories

  1. Physics and mathematics help us better understand how the immune system selects and treats targets
  2. Measurement of antibody activity in blood serum using protein chips
  3. The Binding Landscape of Serum Antibodies: How Physical and Mathematical Concepts can Advance Systems Immunology
  4. Absolute quantitation of serum antibody reactivity using the Richards growth model for antigen microspot titration
  5. Current blood antibody testing is not quantitative even if it is called so
  6. Immunological cells and mechanisms contributing to memory in the immune system
  7. Antibodies in blood form a network, which can be modeled using physics and network science
  8. Network organization of antibody interactions in sequence and structure space: the RADARS model
  9. Quantitative Network Organization of Interactions Emerging from the Evolution of Sequence and Structure Space of Antibodies: the RADARS Model
  10. Thermodynamic projection of the antibody interaction network: The fountain energy landscape of molecular interaction systems
  11. Examining molecular networks in multicellular organisms
  12. Thermodynamic projection of the antibody interaction network: The fountain energy landscape of molecular interaction systems
  13. The Generalized Quantitative Model of antibody homeostasis: maintenance of global antibody equilibrium by effector functions
  14. Detection of red blood cell surface antigens by probe-triggered cell collision and flow retardation in an autonomous microfluidic system
  15. Visualization of complex antibody interactions based on physico-chemical interpretation
  16. A generalized quantitative antibody homeostasis model: antigen saturation, natural antibodies and a quantitative antibody network
  17. A generalized quantitative antibody homeostasis model: regulation of B-cell development by BCR saturation and novel insights into bone marrow function
  18. A generalized quantitative antibody homeostasis model: regulation of B-cell development by BCR saturation and novel insights into bone marrow function
  19. A generalized quantitative antibody homeostasis model: antigen saturation, natural antibodies and a quantitative antibody network
  20. Characterization of NF-κB Reporter U937 Cells and Their Application for the Detection of Inflammatory Immune-Complexes
  21. Measurement of cell binding to solid phase antibodies by plasmon resonance
  22. Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium
  23. Label-free Microfluidic Sensing by Detection of Interaction-triggered Change in Blood Flow Characteristics
  24. Monovalent Fc receptor blockade by an anti-Fc  receptor/albumin fusion protein ameliorates murine ITP with abrogated toxicity
  25. The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability
  26. Lupus pathogenesis and the vascular endothelium
  27. Non-CpG Oligonucleotides Exert Adjuvant Effects by Enhancing Cognate B Cell-T Cell Interactions, Leading to B Cell Activation, Differentiation, and Isotype Switching
  28. Exploiting fluorescence for multiplex immunoassays on protein microarrays
  29. Introduction
  30. Coadministration of antigen-conjugated and free CpG: Effects of in vitro and in vivo interactions in a murine model
  31. Bead Arrays for Antibody and Complement Profiling Reveal Joint Contribution of Antibody Isotypes to C3 Deposition
  32. Built-in adjuvanticity of genetically and protein-engineered chimeric molecules for targeting of influenza A peptide epitopes
  33. Recognition of new citrulline-containing peptide epitopes by autoantibodies producedin vivoandin vitroby B cells of rheumatoid arthritis patients
  34. Application of Fluorescent Monocytes for Probing Immune Complexes on Antigen Microarrays
  35. Generation of Gene-Engineered Chimeric DNA Molecules for Specific Therapy of Autoimmune Diseases
  36. Immune Complex Signatures of Patients with Active and Inactive SLE Revealed by Multiplex Protein Binding Analysis on Antigen Microarrays
  37. FcRn Overexpression in Transgenic Mice Results in Augmented APC Activity and Robust Immune Response with Increased Diversity of Induced Antibodies
  38. Exacerbation of collagen induced arthritis by Fcγ receptor targeted collagen peptide due to enhanced inflammatory chemokine and cytokine production
  39. Life on a microarray: assessing live cell functions in a microarray format
  40. Complementing antibody profiles: Assessing antibody function on antigen microarrays
  41. Introduction
  42. Characterization of factors influencing on-chip complement activation to optimize parallel measurement of antibody and complement proteins on antigen microarrays
  43. Facing challenges in Proteomics today and in the coming decade: Report of Roundtable Discussions at the 4th EuPA Scientific Meeting, Portugal, Estoril 2010
  44. Application of Monoclonal Antibody Therapies in Autoimmune Diseases
  45. The Use of Antigen Microarrays in Antibody Profiling
  46. Modulation of the humoral immune response by targeting CD40 and FcγRII/III; delivery of soluble but not particulate antigen to CD40 enhances antibody responses with a Th1 bias
  47. Elimination of autoreactive B cells in humanized SCID mouse model of SLE
  48. Functional serum antibody profiles in autoimmune disease diagnostics
  49. Transgenic expression of bovine neonatal Fc receptor in mice boosts immune response and improves hybridoma production efficiency without any sign of autoimmunity
  50. Humanized SCID Mice Models of SLE
  51. Targeting Dendritic Cells with Carbon Magnetic Nanoparticles Made by Dense-Medium Plasma Technology
  52. Progression of lupus-like disease drives the appearance of complement-activating IgG antibodies in MRL/lpr mice
  53. Differential expression and function of complement receptor type 1 (CD35) and 2 (CD21) on human B lymphocytes
  54. Dendritic Cells in Chronic Mycobacterial Granulomas Restrict Local Anti-Bacterial T Cell Response in a Murine Model
  55. Re-establishing tolerance to DNA in humanized and murine models of SLE
  56. Modulation of immune response by combined targeting of complement receptors and low-affinity Fcγ receptors
  57. Antigen microarrays: descriptive chemistry or functional immunomics?
  58. Anti-factor B autoantibody in dense deposit disease
  59. Using carbon magnetic nanoparticles to target, track, and manipulate dendritic cells
  60. A novel, complement-mediated way to enhance the interplay between macrophages, dendritic cells and T lymphocytes
  61. CD16/32-specific biotinylated 2.4G2 single-chain Fv complexed with avidin-FITC enhances FITC-specific humoral immune response in vivo in a CD16-dependent manner
  62. Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production
  63. Generation of functional antibody profiles using complement deposition data from protein arrays
  64. Identification and characterization of a factor B autoantibody in membranoproliferative glomerulonephritis type II
  65. Anti-DNA antibodies with IgG isotype override early regulation points of the complement cascade and induce abundant C3 generation
  66. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions
  67. Synthesis of hepcidin derivatives in order to develop standards for immune adsorption method
  68. Egg composition in relation to social environment and maternal physiological condition in the collared flycatcher
  69. Detection of Complement Activation on Antigen Microarrays Generates Functional Antibody Profiles and Helps Characterization of Disease-Associated Changes of the Antibody Repertoire
  70. Advantage of parallel measurement of antibody binding and complement activation on antigen chips
  71. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity☆
  72. Novel roles for murine complement receptors type 1 and 2
  73. Novel roles for murine complement receptors type 1 and 2
  74. An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes
  75. Physiological up-regulation of inhibitory receptors Fc RII and CR1 on memory B cells is lacking in SLE patients
  76. On-chip complement activation for functional profiling of serum antibodies on antigen microarrays
  77. On-chip complement activation is a suitable technique for the simultaneous detection of the presence and complement activating properties of autoantibodies
  78. Altered Expression of Fc  and Complement Receptors on B Cells in Systemic Lupus Erythematosus
  79. Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases
  80. Novel roles of CR1/2 on B lymphocytes
  81. PROHEPCIDIN LEVELS DURING HUMAN PERINATAL ADAPTATION
  82. On-chip Complement Activation Adds an Extra Dimension to Antigen Microarrays
  83. Maternal immunoglobulin concentration in Collared Flycatcher (Ficedula albicollis) eggs in relation to parental quality and laying order
  84. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus
  85. The role of CR2 in autoimmunity
  86. Regulation of B-cell activation by complement receptors CR1 (CD35) and CR2 (CD21)—possible involvement in the pathogenesis of autoimmune diseases
  87. Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays
  88. Regulation of B-Cell Activation by Complement Receptors CD21 and CD35
  89. Targeting with scFv: immune modulation by complement receptor specific constructs
  90. Mucosal type mast cells express complement receptor type 2 (CD21)
  91. Complement Receptor Type 1 (CD35) Mediates Inhibitory Signals in Human B Lymphocytes
  92. Modeling the presentation of C3d-coated antigen by B lymphocytes: enhancement by CR1/2-BCR co-ligation is selective for the co-ligating antigen
  93. Immunomodulatory functions of murine CR1/2
  94. H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells
  95. Inhibition of advanced glycated end-products
  96. Targeting of influenza epitopes to murine CR1/CR2 using single-chain antibodies
  97. Alterations in enzymatic antioxidant defence in diabetes mellitus - a rational approach
  98. Ultrastructural localization of Hsp-72 examined with a new polyclonal antibody raised against the truncated variable domain of the heat shock protein
  99. A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells.
  100. Targeting of influenza epitopes to murine CR1,2 using SCFV antibodies
  101. Coordination of Adaptive Immune Responses by C3
  102. The Role of the Complement System in the Pathogenesis of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
  103. Murine CR1/2 Targeted Antigenized Single-Chain Antibody Fragments Induce Transient Low Affinity Antibodies and Negatively Influence an Ongoing Immune Response